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Alterations in Skeletal Muscle
Oxidative Phenotype in Mice
Exposed to 3 Weeks of
Normobaric Hypoxia
ILSE G.M. SLOT, ANNEMIE M.W.J. SCHOLS, CHIEL C. DE THEIJE, FRANK J.M. SNEPVANGERS,
AND HARRY R. GOSKER*
Department of Respiratory Medicine, NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht
University Medical Centreþ, Maastricht, The Netherlands
Skeletal muscle of patients with chronic respiratory failure is prone to loss of muscle mass and oxidative phenotype. Tissue hypoxia has been
associated with cachexia and emphysema in humans. Experimental research on the role of hypoxia in loss of muscle oxidative phenotype,
however, has yielded inconsistent results. Animal studies are frequently performed in young animals, whichmay hinder translation to generally
older aged patients. Therefore, in this study, we tested the hypothesis that hypoxia induces loss of skeletal muscle oxidative phenotype in a
model of aged (52weeks)mice exposed to 3weeks of hypoxia. Additional groups of young (4weeks) and adult (12weeks)micewere included
to examine age effects. To verify hypoxia-induced cachexia, fat pad and muscle weights as well as muscle ﬁber cross-sectional areas were
determined. Muscle oxidative phenotype was assessed by expression and activity of markers of mitochondrial metabolism and ﬁber-type
distribution. A profound loss ofmuscle and fat was indeed accompanied by a slightly lower expression ofmarkers of muscle oxidative capacity
in the aged hypoxic mice. In contrast, hypoxia-associated changes of ﬁber-type composition were more prominent in the young mice. The
differential responseof themuscle of young, adult, and agedmice tohypoxia suggests that agematters and that the agedmouse is a bettermodel
for translation of ﬁndings to elderly patients with chronic respiratory disease. Furthermore, the ﬁndings warrant furthermechanistic research
into putative accelerating effects of hypoxia-induced loss of oxidative phenotype on the cachexia process in chronic respiratory disease.
J. Cell. Physiol. 231: 377–392, 2016.  2015 Wiley Periodicals, Inc.
Skeletal muscle of patients with chronic obstructive pulmonary
disease (COPD) is often characterized by low muscle mass
(Remels et al., 2013), a reduced proportion of type I oxidative
ﬁbers and a diminished oxidative capacity (Gosker et al., 2000;
Decramer et al., 2005). In advanced disease stages hypoxia, a
condition of inadequate oxygen content in a tissue, has been
proposed as a driver of both phenotypic characteristics
(Gosker et al., 2000; de Theije et al., 2011; Turan et al., 2011).
Indeed the prevalence of weight loss and muscle atrophy is high
in various respiratory disorders that are hallmarked by
hypoxia, including acute exacerbations of COPD (Crul et al.,
2010; Lainscak et al., 2011), idiopathic pulmonary arterial
hypertension (Batt et al., 2014), and acute respiratory distress
syndrome (ARDS) (Herridge et al., 2003), and hypoxia has been
associated with reduced muscle mass (Schols et al., 1989). For
the loss of muscle oxidative phenotype (Oxphen), a role for
hypoxia is supported by observations of reduced proportions
of oxidative type I ﬁbers, decreased aerobic metabolism, and
impaired oxidative capacity in skeletal muscle of patients with
respiratory failure (RF) (Jakobsson et al., 1990; Wuyam et al.,
1992; Jakobsson et al., 1995). Furthermore, Filley et al. (1968)
suggested already in 1968 that tissue hypoxia is responsible for
cachexia in patients with end stage emphysema. Emphysema
has also been associated with a more pronounced type I to II
(oxidative to glycolytic) ﬁber-type shift in skeletal muscle
(Gosker et al., 2002b). Moreover, hypoxemia often develops
or worsens with acute exacerbations (Lainscak et al., 2013),
and patients suffering an acute exacerbation have been shown
to have decreased expression of subunits of mitochondrial
cytochrome c oxidase and ATP synthase in the vastus lateralis
muscle (Crul et al., 2010). The ﬁrst report of an association
between hypoxia and type I ﬁber proportion in human studies
was probably by Jakobsson et al. (1990) who showed an
association between low type I proportion and low arterial
oxygen pressure in patients with RF. Moreover, Wuyam et al.
(1992) reported impaired oxidative capacity in patients with
RF. A few years later, Jakobsson et al. (1995) also described
decreased oxidative enzyme activities in quadriceps muscle of
advanced COPD patients which were partly restored by long-
term oxygen therapy (Jakobsson and Jorfeldt, 1995).
Previous studies involving healthy volunteers as well as
experimental animal models gave inconsistent results with
regard to hypoxia-associated loss of muscle oxidative
phenotype. Human studies involved participants of
mountaineering expeditions that were sampled before and after
the expedition (Boutellier et al., 1983; Howald et al., 1990) and
showed decreased activity of mitochondrial enzymes after
hypoxia exposure. However, mountaineering expeditions are
heavily confounded by strenuous physical activity (Hoppeler
et al., 1990; Howald et al., 1990; Hoppeler and Desplanches,
1992). To control for confounders related to these expeditions,
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such as low temperature, dietary imbalance and extreme
exercise, Green et al. (1989) studied participants who were
placed in a hypobaric chamber. Enzyme activities of citrate
synthase, succinate dehydrogenase, and hexokinase were
repressed, but glycolytic enzymes other than hexokinase did not
change and no ﬁber-type shift was observed (Green et al., 1989).
Many animal studies were performed in rats (Itoh et al., 1990;
Hirofuji et al., 1992; Takahashi et al., 1992; Takahashi et al., 1993;
Abdelmalki et al., 1996; Sillau and Banchero, 1977; Bigard et al.,
2000; Faucher et al., 2005; De Palma et al., 2007). Some of these
studies report a ﬁber-type shift towards fast ﬁbers (Itoh et al.,
1990; Hirofuji et al., 1992; Itoh et al., 1992; Ishihara et al., 1994;
Takahashi et al., 1996; Sillau and Banchero, 1977; Bigard et al.,
2000; Faucher et al., 2005), whereas in others no change of ﬁber-
type composition is observed (Takahashi et al., 1992; Abdelmalki
et al., 1996). In general, hypoxia appears to reduce oxidative
enzyme activities (Takahashi et al., 1993; Abdelmalki et al., 1996;
De Palma et al., 2007), although Takahashi et al. (1996) did not
observe reduced oxidative enzyme activity by hypoxia.
However, some of the reported changes in ﬁber-type
composition and oxidative enzyme activities by hypoxia have
been suggested to be confounded by hypoxia-associated
anorexia (Abdelmalki et al., 1996).
Many of the animal studies have been conducted under
hypobaric hypoxia (Itoh et al., 1990; Itoh et al., 1992; Ishihara
et al., 1994; Bigard et al., 2000), whereas normobaric hypoxia
would bemost appropriate fromaphysiological and pathological
perspective. Also, most of these studies have been conducted in
rats, whereas mouse models are nowadays more suitable
because of the availability of research tools that can be applied
(e.g., antibodies, transgenes). Animal models for COPD are
indeed primarily mouse models, but surprisingly until recently
this did not yet include a well-established hypoxia model
(Marcelino et al., 2014). Moreover, as COPD mainly affects the
elderly, using older animals would be most appropriate or at
least preclude age-related variation in the investigated topic. To
our knowledge, however, old animals are rarely studied to
model disease factors of COPD, except for a recent report by
van den Borst et al. (2013a) investigating effects of hypoxia on
adipose tissue inﬂammation and metabolism. Indeed, the
abovementioned animal studies were conducted in animals of
different ages (juvenile and still developing to barely full-grown),
with age-dependent outcomes (Ishihara et al., 1995). We
recently investigated the direct effect of hypoxia on muscle
oxidative phenotype in vitro (Slot et al., 2014). In line with our
hypothesis, markers of oxidative capacity were signiﬁcantly
reduced by hypoxia, but unexpectedly hypoxia stimulated
expression of the oxidative type Imyosin heavy chain (MyHC). In
vitro cultured myotubes probably reﬂect the developmental
stage of muscle in juvenile animals, further illustrating that age
should be considered in animal models of COPD.
We, therefore, decided to conduct a methodological study
on the effect of normobaric hypoxia on muscle oxidative
phenotype in aged mice (52 weeks of age). We hypothesized
that hypoxia induces loss of oxidative phenotype. In addition,
we veriﬁed hypoxia-associated loss of muscle and fat mass and
we determined protein oxidation levels. For comparison, also
very young (4 weeks old, still growing) and adult (12 weeks old,
limited muscle growth) mice were included.
Materials and Methods
Experimental procedure
A total of 76 male C57BL/6J mice (Charles River Laboratories,
Wilmington, MA) at the age of 4 weeks (young), 12 weeks (adult),
and 52 weeks (aged) were randomly divided over groups that were
subsequently exposed to hypoxia (8% oxygen, n¼ 10 for 4 weeks
and 52 weeks, n¼ 8 for 12 weeks) or ambient air (normoxia, n¼ 8
per age group) for 21 days. Because decreased food intake is
associated with hypoxia exposure and may act as a confounding
factor in interpreting hypoxia-associated changes, an additional
group of mice exposed to normoxia (n¼ 8 per age group) was pair-
fed to match the food intake of the hypoxic mice. Seven mice were
excluded because of infection (1 in 4 weeks hypoxic group, 2 in each
of 4 weeks normoxic, and 52weeks normoxic and hypoxic groups).
Baseline characteristics but not the primary outcome (Oxphen) of
only the 52-week-old normoxic and hypoxic but not pair-fed mice
have been previously reported (van den Borst et al., 2013a).
Mice were housed in experimental chambers at 21°Cwith a 12-h
dark/light cycle and received standard chow (V1534–000 ssniff R/M-
H, ssniff Spezialdi€aten, Soest, Germany) and water ad libitum. For
the hypoxia experiments, oxygen was replaced by nitrogen by the
ProOx P110 oxygen controller (BioSpherix, Lacona, NY) in a
stepwisemanner to create normobaric oxygen levels of 12% (day 1),
10% (day 2), and ﬁnally 8% (60.8mmHg) on day 3 and the remainder
of the experiment. Three to four mice were housed per cage. Daily
food intake was determined per cage. On day 21, mice were
anesthetized with isoﬂurane gas, the abdominal cavity was opened,
and aortic blood was collected into a heparin-coated 1-ml syringe
(BectonDickinson, Breda, TheNetherlands). Oxygen levels and pH
weremeasured immediately using the ABL 510 BloodGas Analyzer
(Radiometer; Diamond Diagnostics, Holliston, MA) and blood cell
count was determined with the Coulter Ac T Diff Hematology
Analyzer (Beckman Coulter, Woerden, The Netherlands).
Plasma was stored at –80°C until further analyses. Lower limb
skeletal muscles (gastrocnemius, tibialis anterior, soleus [SOL],
extensor digitorum longus [EDL], and plantaris), were dissected
and weighed. One of each muscle was embedded in Tissue-Tek
(Sakura Finetek Europe, Zoeterwoude, The Netherlands) and
frozen in melting isopentane precooled in liquid nitrogen and
stored at80°C for histology. The other muscle was snap-frozen
in liquid nitrogen and stored at –80°C for molecular analyses. The
protocol was approved by the Committee for Animal Care and
Use of Maastricht University (project 2009-151).
Immunohistochemistry
Muscle cryosections (7mm) with ﬁbers in transverse orientation
were incubatedwith primary anti-myosin heavy chain (MyHC) I, anti-
MyHC IIa (both Developmental Studies Hybridoma Bank (DSHB),
University of Iowa, USA), and anti-laminin (Sigma, Zwijndrecht, The
Netherlands) followed by secondary antibodies labeled with Alexa
Fluor 555, Alexa Fluor 488, and Alexa Fluor 350 (Invitrogen, Breda,
The Netherlands). Stained sections were microscopically
photographed at 200 magniﬁcation (Nikon Eclipse E800; Nikon
Instruments Europe, Amsterdam, The Netherlands). In a blinded
fashion, ﬁber types were classiﬁed based on their MyHC isotype
content (ﬁber type I and IIa positive for MyHC isotype I and IIa,
respectively; hybrid type I/IIa positive for both MyHC isotypes I and
IIa; types IIb and IIx together remain unstained) and ﬁber cross-
sectional area was measured with Lucia 4.82 software (Laboratory
Imaging, Czech Republic) based on laminin staining of the basement
membrane (Verdijk et al., 2007). The number of ﬁbers analyzed per
ﬁber type is listed in Supplemental Table S1.
Enzyme activity assays and immunoblotting
One soleus and one EDL muscle were each homogenized in 240ml
ice-cold SET buffer (250mM sucrose, 2mM EDTA, 10mM Tris, pH
7.4) using a Mini-BeadBeater (BioSpec Products, Inc., Bartlesville,
OK) and incubatedon ice for 10min. Sampleswere spun for 5min at
maximum speed (20,817g) in a cooled centrifuge and supernatant
was collected. Pelletswere snap-frozen in liquid nitrogen and stored
at –80°C for later analysis. Supernatants were divided into three
aliquots. To the ﬁrst aliquot, aqueous BSA solution was added to a
ﬁnal concentration of 1% (v/v) and snap-frozen to be stored at
–80°C until analysis of enzymatic activity. The second aliquot was
supplemented with 4 sample buffer (250mM Tris-HCl pH6.8, 8%
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(w/v) sodium dodecyl sulfate, 40% (v/v) glycerol, 0.4M
dithiothreitol, 0.02% (w/v) bromophenol blue), and samples were
snap-frozen and stored until analysis by Western blot. The third
aliquot of lysate was used to determine the protein concentration
with the bicinchoninic acid assay (Pierce, Thermo Fisher Scientiﬁc,
Breda, The Netherlands) according to manufacturer’s instructions.
Citrate synthase (CS, EC 2.3.3.1), 3-hydroxyacyl-CoA
dehydrogenase (HADH, EC 1.1.1.35), cytochrome c oxidase
(COX, EC 1.9.3.1), and phosphofructokinase (PFK, EC 2.7.1.11)
activities were assayed spectrophotometrically (Multiskan
Spectrum; Thermo Labsystems, Breda, The Netherlands) as
previously described (Ling et al., 1966; Shepherd and Garland,
1969; Bergmeyer et al., 1974; Gohil et al., 1981). Absolute CS,
HADH, COX, and PFK activities were normalized to total protein.
For immunoblotting, 10mg of unboiled protein in sample buffer
was separated by electrophoresis in a gradient gel (4–12% Bis–Tris
XT gel, Criterion, Bio-Rad, Veenendaal, The Netherlands) with XT
MOPS running buffer (Bio-Rad). Samples from the same age group
and the same muscle were run together on the same gel. Proteins
were transferred to a 0.45mm nitrocellulose membrane (Protran,
Schleicher and Schuell, ‘s-Hertogenbosch, The Netherlands) in
transfer buffer (25mM Tris, 192mM glycine, 20% (v/v) methanol).
After transfer, proteins were visualized using Ponceau S staining
solution (Sigma–Aldrich, St. Louis, MO). Membranes were
subsequently blocked from nonspeciﬁc protein binding with
blocking solution, which contains 5% (w/v) non-fat dry milk
(Campina, Eindhoven, The Netherlands) in Tris-buffered saline
with Tween-20 (TBST; 25mM Tris, 137mM NaCl, 2.7mM KCl,
0.05% (v/v) Tween-20, pH 7.4), for 1 h at room temperature,
followed by incubation in primary antibody solution overnight at
4°C (mouse anti-Total OXPHOS Rodent WB Antibody Cocktail
(MS604-300, Abcam, Cambridge, UK; the cocktail contains 5mAbs,
one each against CI subunitNDUFB8, CII-30kDa,CIII-Core protein
2, CIV subunit I and CV alpha subunit) or rabbit anti-PGC-1a
antibody (#516557, Calbiochem, Nottingham, United Kingdom)
diluted1:1,000 inblocking solution). Thenext day,membraneswere
incubated in secondary antibody solution (peroxidase-labeled horse
anti-mouse IgG or goat anti-rabbit IgG (PI-2000 and PI-1000,
respectively; Vector Laboratories, Burlingame, CA) diluted 1:5,000
in blocking solution) for 1 h at room temperature before incubation
with enhanced chemiluminescence substrate (Pierce SuperSignal
West PICO Chemiluminescent Substrate; Thermo Fisher
Scientiﬁc). Protein bands were detected using LAS-3000
Luminescent Image Analyzer (Fujiﬁlm, Tokyo, Japan). Bands were
quantiﬁed using AIDA Image Analyzer software (Fujiﬁlm) and
corrected for loading differences by the Ponceau S staining intensity.
Protein oxidation was detected with the Oxyblot kit according
to the manufacturer’s instructions (Chemicon International,
Temecula, CA). Brieﬂy, carbonyl groups in the protein side chains
were derivatized to 2,4-dinitrophenylhydrazone (DNP) and
immunoblotted according to the procedure described above. In
addition, for each animal an underivatized sample was included, for
which the derivatized sample was corrected in the analysis. After
analysis of oxidation, the blot was reprobed for GAPDH (rabbit
anti-GAPDH, #2118; Cell Signaling Technology, Leiden, The
Netherlands; procedure as described above) to correct for
differences in protein loading.
Gene expression analysis
RNA was extracted from muscle tissue leftovers from
cryosectioning using the RNeasy Fibrous Tissue kit (Qiagen, Venlo,
The Netherlands) according to the supplier’s protocol. Samples
were homogenized using a Mini-BeadBeater (BioSpec Products,
Inc.). After elution, RNA concentration was determined using a
spectrophotometer (NanoDrop ND-1000, Isogen Lifescience,
IJsselstein, The Netherlands) and integrity veriﬁed for a selection
of samples by gel electrophoresis and on a Bioanalyzer (Agilent
Technologies, Amstelveen, The Netherlands). Approximately
500 ng of RNA was reverse transcribed to cDNA with random
hexamer primers according to the supplier’s protocol
(Transcriptor First Strand cDNA Synthesis kit, Roche Diagnostics,
Woerden, The Netherlands). RT-qPCR primers were designed
based on Ensembl transcript sequences and ordered from Sigma
Genosys (Zwijndrecht, The Netherlands). Primer sequences are
listed in Table 1. RT-qPCR reactions contained SensiMix SYBR Hi-
ROX Kit (Quantace-Bioline, London, UK) with 300 nM primers
and were run in 384-well MicroAmp Optical 384-Well Reaction
Plate (Applied Biosystems, Nieuwerkerk a/d IJssel, The
Netherlands) on a 7900HT Fast Real-Time PCR System (Applied
Biosystems). Standard curves, prepared from pooled cDNA, and
melt curves were analyzed to verify efﬁciency and speciﬁcity of
ampliﬁcation. Seven reference genes (18s, Axin1, B2m, Canx, Ppia,
Rplp0, and Tuba1a) were measured and stability of expression was
assessed by visual inspection of expression differences between
the study groups and a stability assessment by geNorm
(Vandesompele et al., 2002). Eventually, six reference genes (all but
Rplp0) were used to calculate a geNorm factor, which was used to
normalize expression levels of the target genes.
Statistics
Comparisons between the groups weremade using Kruskal–Wallis
non-parametric ANOVA (post hoc Mann–Whitney U with
Bonferroni correction), which is most appropriate for the current
group sizes. Extreme outliers were removed from the analysis. To
test the effect of age in the hypoxic group, per age group the values
of the hypoxic animals were expressed as a percentage of those of
the normoxic animals and compared as said above. Correlations
were tested using the Pearson correlation coefﬁcient. Analyses
were performedusing IBMSPSS Statistics 22.0 (IBMCorp., Armonk,
NY). A P-value <0.05 was considered statistically signiﬁcant.
Results
Arterial blood gas and hematological adaptations
The arterial blood of hypoxic mice of all ages showed increased
acidosis, hypoxemia, and polycythemia (Tables 2, 3, and 4).
Body weight
Hypoxia signiﬁcantly reduced body weight of aged mice
(Fig. 1A). In response to the initiation of the experiment,
hypoxic mice showed a reduced food intake (Fig. 1B).
However, after approximately 9 days, food intake was
normalized to that of normoxic animals and body weight loss
after 21 days of hypoxia was signiﬁcantly stronger in the
hypoxic than in the pair-fed aged mice (P¼ 0.002; Fig. 1A).
Together, these data reveal a food intake-independent effect of
hypoxia on body weight.
Fat pad and muscle weights and muscle ﬁber
cross-sectional area
Hypoxia-associated body weight loss was reﬂected by hypoxia-
induced reductions of fat pad (Fig. 1C) and muscle weights
(Fig. 1D); this loss was only partly dependent on the reduced
food intake.
Whereas soleus showed a discrepancy between muscle
weight and ﬁber cross-sectional area in the aged mice
(Fig. 1D and E), EDL mean ﬁber cross-sectional area (Fig. 1F)
closely resembled the changes in EDL muscle weight (Fig. 1D).
The ﬁbers in the EDL seemedmost affected by hypoxia, with no
additional effect of reduced food intake. In the soleus, food
intake appears to have a larger role in atrophy, although
changes between pair-fed and normoxia are not signiﬁcant,
except for type I/IIa and IIx/b ﬁbers. Overall, hypoxia thus
affected muscle ﬁber cross-sectional area in both a food intake-
dependent and -independent manner.
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Muscle ﬁber-type composition and ﬁber-speciﬁc myosin
heavy chain (MyHC) expression in skeletal muscle
Hypoxia increased soleus hybrid type I/IIa ﬁber proportion
(Fig. 2A). On the level of gene expression, the hypoxic aged
mice showed decreased MyHC type IIb in the soleus (Fig. 2C)
and increased MyHC type I in the EDL (Fig. 2D).
Metabolic enzyme activities in skeletal muscle
Phosphofructokinase (PFK) activity was signiﬁcantly increased
by hypoxia in the soleus (Fig. 3A) and EDL (Fig. 3B) of aged
mice. The aged hypoxic mice showed a slight reduction of
citrate synthase (CS) activity in the EDL (Fig. 3B) but no change
in cytochrome c oxidase (COX) activity (Fig. 3A and B).
Changes in 3-hydroxyacyl-CoA dehydrogenase (HAD) activity
were non-signiﬁcant.
Protein and gene expression levels of mitochondrial
components
To assess whether reduced citrate synthase activity was
associated with a reduced mitochondrial content, we measured
protein content of ﬁve subunits of the oxidative phosphorylation
(OXPHOS) chain. There was generally no sign of repressed
contentof these subunits in soleus (Fig. 3C; a representativeblot is
included in Supplemental Figure S1), nor in EDL (Fig. 3D) of aged
hypoxic mice. In contrast, gene expression levels of some
OXPHOS subunits were repressed (Fig. 3E and F). These changes
were sometimes partly caused by the reduced food intake.
TABLE 1. Primer sequences used for RT-qPCR
Symbol Name Ensembl ID Forward primer (50!30) Reverse primer (50!30)
Amplicon
size (bp)
Axin1 Axin 1 ENSMUSG00000024182 AGTGGATCATTGAGGGAGAGA GCCCCAGGACGCTCGAT 124
B2m b-2-microglobulin ENSMUSG00000060802 CTTTCTGGTGCTTGTCTCACTGA GTATGTTCGGCTTCCCATTCTC 104
Canx Calnexin ENSMUSG00000020368 GCAGCGACCTATGATTGACAACC GCTCCAAACCAATAGCACTGAAAGG 170
Cox5a Cytochrome c oxidase
subunit Va
ENSMUSG00000000088 TGCGAGCATGTAGACCGTTAAAT GAGGTCCTGCTTTGTCCTTAACA 77
Cyc1 Cytochrome c-1 ENSMUSG00000022551 GCATTCGGAGGGGTTTCCAG CCGCATGAACATCTCCCCA 176
Esrra Estrogen-related
receptor alpha
ENSMUSG00000024955 GGCGGACGGCAGAAGTACAAA GCGACACCAGAGCGTTCAC 130
Gabpa GA binding protein
alpha; nuclear
respiratory factor 2
alpha
ENSMUSG00000008976 TGCTGCACTGGAAGGCTACA TTACCCAAACCACCCAATGC 104
mt-Co2 Cytochrome c oxidase
subunit II
ENSMUSG00000064354 CCATCCCAGGCCGACTAA ATTTCAGAGCATTGGCCATAGAA 76
Myh1 Myosin heavy chain 1
(type IIx isoform)
ENSMUSG00000056328 GACAAACTGCAATCAAAGG TTGGTCACTTTCCTGCACTT 231
Myh2 Myosin heavy chain 2
(type IIa isoform)
ENSMUSG00000033196 CGATGATCTTGCCAGTAATG ATAACTGAGATACCAGCG 221
Myh4 Myosin heavy chain 4
(type IIb isoform)
ENSMUSG00000057003 AGGGCGGCGGTGGAA TGGGAATGAGGCATCTGACAA 141
Myh7 Myosin heavy chain 7
(type I isoform)
ENSMUSG00000053093 CAGATCGGGAGAATCAGTCCAT AGCAAAATATTGGATGACCCTCTTA 89
Ndufb3 NADH dehydrogenase
(ubiquinone) 1 beta
subcomplex 3
ENSMUSG00000026032 ACAGACAGTGGAAAATTGAAGGG GCCCATGTATCTCCAAGCCT 110
Nrf1 Nuclear respiratory
factor 1
ENSMUSG00000058440 AGCCACATTGGCTGATGCTT GGTCATTTCACCGCCCTGTA 124
Ppara Peroxisome
proliferator-activated
receptor alpha
ENSMUSG00000022383 ACTACGGAGTTCACGCATGTG TTGTCGTACACCAGCTTCAGC 76
Ppard Peroxisome
proliferator-activated
receptor delta
ENSMUSG00000002250 AGGCCCGGAGCATCCTCA TGGATGACAAAGGGTGCGTTG 55
Pparg Peroxisome
proliferator-activated
receptor gamma
ENSMUSG00000000440 CGGAAGCCCTTTGGTGACTT TGGGCTTCACGTTCAGCAAG 148
Ppargc1a Peroxisome
proliferator-activated
receptor gamma
coactivator 1 alpha
ENSMUSG00000029167 CAACAATGAGCCTGCGAACA CTTCATCCACGGGGAGACTG 104
Ppargc1b Peroxisome
proliferator-activated
receptor gamma
coactivator 1 beta
ENSMUSG00000033871 ACCCTGAGAAAGCGCAATGA CCCAGATGAGGGAAGGGACT 120
Ppia Peptidyl-prolyl cis-trans
isomerase A;
Cyclophilin A
ENSMUSG00000071866 TTCCTCCTTTCACAGAATTATTCCA CCGCCAGTGCCATTATGG 75
Rn18s 18S ribosomal RNA RefSeq NR_003278.1 AGTTAGCATGCCAGAGTCTCG TGCATGGCCGTTCTTAGTTG 76
Rplp0 Large ribosomal
protein P0
ENSMUSG00000067274 GGACCCGAGAAGACCTCCTT GCACATCACTCAGAATTTCAATGG 85
Sdhb Succinate
dehydrogenase
complex, subunit B
ENSMUSG00000009863 AATTTGCCATTTACCGATGGGA AGCATCCAACACCATAGGTCC 104
Tfam Mitochondrial
transcription
factor A
ENSMUSG00000003923 CCGGCAGAGACGGTTAAAAA TCATCCTTTGCCTCCTGGAA 129
Tuba1a Tubulin, alpha 1A ENSMUSG00000072235 CGTAGACCTGGAACCCACGGT TGCCTGTGATGAGCTGCTCA 86
No existing Ensembl ID.
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TABLE 2. Arterial blood gas analysis and hematological adaptations in aged (52 week old) mice
Normoxia Pair-fed Hypoxia
Arterial blood gas analysis
pH 7.28 (7.25, 7.30) 7.35 (7.30, 7.37)

7.10 (7.06, 7.16)
 ,#
PaO2, mmHg 129.5 (120.4, 139.1) 133.7 (128.6, 136.5) 33.8 (33.3, 34.4)
 ,#
PaCO2, mmHg 36.2 (28.1, 41.0) 29.0 (28.3, 34.3) 35.5 (31.3, 37.6)
HCO3
, mM 16.3 (13.2, 18.4) 16.5 (16.1, 18.1) 10.4 (9.4, 12.0)
 ,#
SaO2, % 101 (100, 101) 102 (101, 102) 24 (19, 27)
 ,#
Base excess, mEq L1 9.9 (11.7, 7.6) 7.2 (8.5, 7.0) 22.6 (24.0, 17.7) ,#
Hematological adaptations
Hematocrit, % 0.46 (0.44, 0.47) 0.45 (0.44, 0.47) 0.76 (0.74, 0.78)
 ,#
Hemoglobin, mM 9.0 (8.6, 9.5) 8.7 (8.2, 9.3) 14.5 (14.2, 14.7)
 ,#
Erythrocytes, 106 10.0 (9.4, 10.0) 9.7 (9.5, 10.2) 13.5 (13.3, 13.8) ,#
MCV, fL 45.8 (45.7, 46.1) 46.3 (45.8, 46.9) 55.3 (54.7, 58.4)
 ,#
MCH, pg 0.91 (0.89, 0.92) 0.89 (0.88, 0.91) 1.08 (1.02, 1.10)
 ,#
MCHC, g dl1 20.0 (19.3, 20.2) 19.1 (18.5, 19.7) 19.1 (18.3, 19.6)
p50 (a) 29.6 (28.7, 30.9) 27.6 (26.8, 29.0) 50.8 (49.9, 51.6)
 ,#
Spleen (g) 80.6 (66.1, 90.3) 82.7 (77.6, 92.6) 215.1 (159.7, 238.9)
 ,#
MCV, mean corpuscular volume; MCH, mean corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin concentration.
Values are median (25th percentile, 75th percentile). Blood gas data were available for six normoxic, seven pair-fed, and six hypoxic mice.
P< 0.05 compared to normoxic mice.
#P< 0.05 compared to pair-fed mice. Data partly overlap with our previous study (van den Borst et al., 2013a).
TABLE 3. Arterial blood gas analysis and hematological adaptations in young (4 week old) mice
Normoxia Pair-fed Hypoxia
Arterial blood gas analysis
pH 7.31 (7.26, 7.34) 7.31 (7.26, 7.33) 7.16 (7.09, 7.19)
 ,#
PaO2, mmHg 134.9 (132.1, 150.6) 135.6 (131.1, 138.4) 41.9 (37.8, 43.1)
 ,#
PaCO2, mmHg 23.3 (22.5, 32.3) 30.5 (26.4, 33.0) 28.0 (23.7, 29.0)
HCO3
, mM 12.4 (11.2, 13.9) 14.9 (12.9, 16.3) 8.6 (7.6, 10.4)
 ,#
SaO2, % 101 (101, 102) 101 (100, 101) 33 (27, 37)
 ,#
Base excess, mEq L1 12.5 (13.3, 11.3) 10.2 (11.7, 8.6) 21.8 (25.7, 18.0) ,#
Hematological adaptations
Hematocrit, % 0.36 (0.35, 0.36) 0.37 (0.36, 0.39) 0.64 (0.61, 0.65)
 ,#
Hemoglobin, mM 7.9 (7.8, 8.0) 8.4 (8.0, 8.8) 13.8 (13.1, 13.9)
 ,#
Erythrocytes, 106 8.6 (8.4, 8.8) 9.0 (8.7, 9.3) 13.1 (12.7, 13.3) ,#
MCV, fL 41.3 (41.0, 41.6) 41.4 (41.1, 42.0) 48.2 (47.8, 49.3)
 ,#
MCH, pg 0.92 (0.91, 0.92) 0.93 (0.91, 0.94) 1.03 (1.02, 1.04)
 ,#
MCHC, g dl1 22.3 (21.9, 22.4) 22.3 (22.1, 22.4) 21.3 (21.2, 21.6)
 ,#
p50 (a) 28.3 (27.4, 30.2) 28.7 (28.0, 30.1) 53.3 (49.7, 56.6)
 ,#
Spleen (g) 69.1 (67.5, 71.9) 51.8 (50.2, 57.3)

73.2 (63.5, 86.1)
#
MCV, mean corpuscular volume; MCH, mean corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin concentration.
Values are median (25th percentile, 75th percentile). Blood gas data were available for six normoxic, eight pair-fed, and eight hypoxic mice.
P< 0.05 compared to normoxic mice.
#P< 0.05 compared to pair-fed mice.
TABLE 4. Arterial blood gas analysis and hematological adaptations in adult (12 week old) mice
Normoxia Pair-fed Hypoxia
Arterial blood gas analysis
pH 7.38 (7.34, 7.39) 7.31 (7.29, 7.36)

7.17 (7.14, 7.19)
 ,#
PaO2, mmHg 139.5 (132.6, 143.7) 138.9 (132.7, 142.0) 35.9 (34.1, 37.6)
 ,#
PaCO2, mmHg 27.6 (26.4, 29.6) 28.2 (27.2, 31.2) 30.6 (27.7, 32.4)
HCO3
, mM 15.3 (15.0, 16.5) 14.2 (13.8, 15.1) 10.5 (9.9, 11.6)
 ,#
SaO2, % 101 (101, 102) 101 (101, 101) 27 (23, 29)
 ,#
Base excess, mEq L1 7.9 (8.0, 6.7) 10.2 (10.8, 9.6) 18.1 (20.7, 17.4) ,#
Hematological adaptations
Hematocrit, % 0.38 (0.36, 0.42) 0.39 (0.38, 0.50) 0.71 (0.64, 0.77)
 ,#
Hemoglobin, mM 8.2 (7.8, 8.6) 8.8 (8.6, 10.3)

14.2 (13.5, 14.6)
 ,#
Erythrocytes, 106 9.1 (8.9, 9.4) 10.4 (9.5, 11.0) 14.0 (13.5, 14.2) ,#
MCV, fL 40.5 (40.4, 45.1) 40.4 (40.0, 45.7) 50.1 (47.1, 54.5)
 ,#
MCH, pg 0.88 (0.87, 0.91) 0.91 (0.89, 0.95) 1.01 (0.99, 1.04)
 ,#
MCHC, g dl1 21.5 (20.2, 21.8) 22.3 (20.8, 22.6) 20.1 (19.1, 21.3)
p50 (a) 26.7 (26.3, 28.1) 28.5 (27.0, 29.1)

51.5 (49.6, 53.2)
 ,#
Spleen (g) 72.9 (66.5, 74.6) 61.4 (58.8, 66.8) 135.2 (128.7, 194.1)
 ,#
MCV, mean corpuscular volume; MCH, mean corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin concentration.
Values are median (25th percentile, 75th percentile). Blood gas data were available for seven normoxic, seven pair-fed, and eight hypoxic mice.
P< 0.05 compared to normoxic mice.
#P< 0.05 compared to pair-fed mice.
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Expression of key regulators of muscle oxidative
phenotype in skeletal muscle
Because gene expression of some of the OXPHOS subunits
was repressed by hypoxia, wemeasured gene expression levels
of important regulators of oxidative phenotype. Expression of
PGC-1a, PGC-1b, and ERRa was reduced by hypoxia, but
mainly in the soleus of aged mice (Fig. 3G). We could however
not detect differences in PGC-1a content (Fig. 3H).
Age-dependent differences in hypoxia effects on body and
muscle composition
Age-related differences of hypoxia-associated changes were
observed on body weight, ﬁber-type composition, and
OXPHOS gene expression. In response to hypoxia, the aged
mice lost body weight, which was still signiﬁcantly decreased at
day 21 compared to the normoxic as well as the pair-fed
animals (Fig. 1A). In contrast, the body weight of the adult
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hypoxic mice had recovered by the end of the experiment
(Fig. 4A). The hypoxic young mice had signiﬁcantly lower body
weights by the end of the experiment, but this was not different
compared to pair-fed mice (Fig. 5A). In the young mice,
reduced body weight appeared to be related to a food-
dependent stagnation of growth rather than weight loss as was
observed in the aged animals.
Hypoxic mice of all ages showed an increased proportion of
hybrid type I/IIa ﬁbers in the soleus (Figs. 2, 6, and 7), but in
addition the young mice showed a signiﬁcant decrease of the
type IIa ﬁber proportion (Fig. 6A). Furthermore, MyHC type I
gene expression was increased in the soleus of young hypoxic
mice (Fig. 6C). In summary, hypoxia appears to cause a change in
soleus ﬁber-type distribution in mice of all ages, although a
direction can only be discerned in the youngmice: the increased
hybrid type I/IIa and decreased type II proportions combined
with the increased gene expression levels of type IMyHCappear
to indicate a ﬁber shift from type IIa ﬁbers towards hybrid
type I/IIa ﬁbers. The more apparent ﬁber-type changes in the
young mice were in contrast to the hypoxia-associated
repression of OXPHOS subunit gene expression, which was
generally strongest in the aged hypoxic mice (Figs. 3, 8, and 9).
Protein oxidation of muscle proteins
To assess whether oxidative stress was increased in the muscle
after exposure to hypoxia, we measured protein carbonylation
in the soleus and EDL (Fig. 10). There were no signiﬁcant
differences, except for the EDL of 4-week-old mice, where
oxidation was signiﬁcantly lower with pair-feeding and hypoxia.
Protein carbonylation in the EDL of 4-week-old mice
correlated signiﬁcantly with COX activity (Fig. 10C).
Discussion
Inthisstudy,weshowthat3weeksofhypoxiaonlymildlyattenuates
muscleoxidativephenotypeinmice,whereasmuscleweightandfat
weight are clearly decreased in a hypoxia-dependent manner.
Moreover, hypoxia-associated changes were age-dependent:
alteredﬁber-typecompositionwasmostprominent inyoungmice,
whereasagedmicespeciﬁcallyshowhypoxia-associatedreductions
of mitochondrial regulators and components.
In the current study, we aimed to establish the effect of
hypoxia on muscle oxidative phenotype in aged mice to be able
to translate these ﬁndings to patients with COPD and chronic
respiratory failure, which predominates in the older
population. Hence, we mainly focused on 52-week-old mice in
this study. Ishihara et al. (1995) indeed showed that the age of
rats exposed to hypoxia affects how hypoxia impacts muscle
ﬁber-type composition. Limb muscles of rats undergo a
postnatal shift from glycolytic to oxidative ﬁber types (Wigston
and English, 1992). Hypoxia exposure during this
developmental period supposedly inhibits this shift and results
in a smaller proportion of oxidative ﬁbers in hypoxic young rats
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(Ishihara et al., 1995). However, Wigston and English (1992)
showed that murine postnatal development of the muscle does
not include a shift in ﬁber type towards oxidative ﬁbers.
Therefore, an inhibition of such developmental shift by hypoxia
is not to be expected in mice. Nevertheless, we found an effect
of age on the hypoxia response, because changes in ﬁber-type
composition were more prominent, albeit still modest, in the
youngest mice. This is potentially related to a higher adaptive
plasticity of muscle in young compared to old mice, analogous
to what has been observed in response to electrical stimulation
(Ljubicic et al., 2009) and denervation (O’Leary et al., 2013).
Interestingly, the young mice exposed to hypoxia appear to
shift towards type I/IIa ﬁbers in the soleus, with a concomitant
reduction of the proportion of type IIa ﬁbers, suggesting co-
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expression of MyHC I in IIa ﬁbers. It should be noted that the
proportion of type I/IIa ﬁbers is still small (median 4.2%,
interquartile range [1.85; 6.34]). An increase of MyHC I
expression is, however, in line with our recent in vitro ﬁndings,
where hypoxia exposure of C2C12 myotubes stimulated the
expression of type I MyHC gene and protein (Slot et al., 2014).
In soleus muscle of mice, it has been shown that type IIa ﬁbers
have a higher oxidative potential than type I ﬁbers (Bloemberg
and Quadrilatero, 2012). Moreover, Gouspillou et al. (2014)
recently reported on variations in rodent and human muscle
ﬁber types: whereas mouse type IIa ﬁbers have a higher
mitochondrial content than type I, in human muscle type I is
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more enriched in mitochondria than type IIa. Therefore, a shift
from type IIa ﬁbers to type I/IIa ﬁbers and/or type IIx/b ﬁbers in
mouse could be adaptive to decrease oxidative phenotype in
the muscle in response to reduced oxygen supply. This would
be analogous to a type I to II ﬁber-type shift in the skeletal
muscle of COPD patients, where ﬁbers also shift towards less
oxidative types. The ﬁnding that ﬁber-type changes appear
more prominent in the young mice suggests that hypoxia
mainly affects developing muscle ﬁbers and could implicate that
hypoxia-associated ﬁber-type changes occur during the muscle
regeneration phase in patients with COPD.
Although the changes in ﬁber-type composition are
associated with decreased citrate synthase activity, no change
in protein expression levels of OXPHOS subunits was
apparent. In contrast, patients with mild to moderate COPD
were shown to have decreased content of several OXPHOS
subunits in the quadriceps muscle (van den Borst et al., 2013b).
Possibly, the changes in the hypoxic mice aremodest due to the
relative short period of hypoxia exposure. Expression of PGC-
1a, PGC-1b, and ERRa, which are important regulators of
mitochondrial biogenesis (Wu et al., 1999; Schreiber et al.,
2004; Bastin et al., 2008), was repressed in the aged mice. This
is in line with the reduced gene expression of OXPHOS
subunits in soleus of the aged mice and could indicate that
changes were still under way. In line with results in patients
with chronic respiratory failure, we found that cytochrome c
oxidase (COX) activity was signiﬁcantly increased in the young
hypoxic mice. In the patients, COX activity inversely correlates
with arterial oxygen pressure (Sauleda et al., 1998). Altogether,
hypoxia-associated changes of muscle Oxphen appear subtle in
the mice, which is in line with the modest response of HIF-1
signaling in response to hypoxia in human skeletal muscle
(Lundby et al., 2009) as well as our recent ﬁnding that hypoxia-
associated changes of OXPHOS andMyHCI gene expression in
vitro were HIF-dependent (Slot et al., 2014).
Hypoxia stimulated ﬁber atrophy in both soleus and EDL.
Again, age appeared to affect the hypoxia effect, as the
strongest decrease of cross-sectional area appeared to occur
in the aged mice, but this difference between age groups was
not signiﬁcant (data not shown). Especially the type II ﬁbers
were prone to atrophy. This is in line with skeletal muscle of
patients with COPD, where atrophy is most pronounced in
type II ﬁbers (Gosker et al., 2002a). A sensitivity of glycolytic
ﬁbers for hypoxia-associated atrophy has been reported
before (de Theije et al., 2015). Hypoxia has been shown to
induce expression of myostatin (MSTN) (Hayot et al., 2011).
Moreover, MSTN expression is positively correlated to MyHC
type IIb content (Carlson et al., 1999). These two observations
may explain why type II ﬁbers are more prone to hypoxia-
associated ﬁber atrophy. Interestingly, Hayot et al. showed
increased MSTN expression in chronic hypoxemic COPD
patients as well (Hayot et al., 2011).
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The difference in muscle weight between normoxic and
hypoxic animals was largest in the young mice. Possibly, this is
the result of retarded growth rather than increased weight
loss. This suggestion is indeed supported by the body weight
response, which shows growth retardation rather than weight
loss in both pair-fed and hypoxic young mice; the similar body
weights in pair-fed and hypoxic mice indicate that growth
retardation occurred mainly due to reduced food intake and
not due to hypoxia per se. In the adult mice, reduced food
intake was also the main reason for loss of body weight.
However, in the aged mice hypoxia had an additive effect to
reduced food intake on the body weight loss, which suggests
that aged mice are more susceptible to hypoxia-associated
weight loss. Interestingly, weights of the epididymal and inguinal
fat depots in the hypoxic mice were signiﬁcantly reduced
compared to those of both pair-fed and normoxic mice. This
suggests that fat weight is lost in the hypoxic animals
independent of the reduced food intake. Possibly, this is an
indication of an altered metabolic rate under inﬂuence of
hypoxia. Indeed, we recently reported increased expression of
oxidative metabolic markers and lipolysis genes in the fat
depots in hypoxia-exposed aged mice (van den Borst et al.,
2013a). The increased lipolysis could result in more circulating
fatty acids that in turn stimulate expression of oxidative type I
MyHC in the muscle, possibly through PPARd which has been
shown to shift MyHC content to slower isoforms (Lunde et al.,
2007). Moreover, chronic administration of arachidonic acid to
aged rats has been shown to increase the number of MyHCI-
positive cells and increase the relative content of MyHCIIx
while reducing MyHCIIb content (Inoue et al., 2014).
We found that muscle of aged mice was most affected by
hypoxia both in terms of markers of oxidative capacity and
ﬁber cross-sectional area. We expected that muscle of young
mice would be characterized by a stronger adaptive plasticity,
because increasing age has been shown to reduce the amplitude
of adaptations in response to stresses such as limb ischemia,
chronic electrical stimulation and disuse caused by denervation
(Rivard et al., 1999; Rivard et al., 2000; Ljubicic et al., 2009;
O’Leary et al., 2013). For example, attenuated hypoxia-
associated induction of VEGF expression has been shown in
aged rabbits (Rivard et al., 2000). This was associated with
reduced HIF-1 activity (Rivard et al., 2000) and is suggested to
explain the impairment of angiogenesis in response to ischemia
in old compared to young mice and rabbits (Rivard et al., 1999).
This could imply that young mice adapt better to hypoxic
conditions by improving capillarization, and therefore, can
maintain Oxphen status. An impaired capillary adaptability in
the agedmice could thus underlie the more pronounced loss of
muscle Oxphen observed in these mice.
Another explanation for the stronger effects of hypoxia in
the aged mice is accumulation of oxidative stress-derived
damage during their life. Postmitotic cells have been shown to
be more prone to accumulate oxidative damage (Radak et al.,
2001). This damage could make the cells more sensitive to
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hypoxia or less effective in compensation of hypoxia-associated
stress. Moreover, it has been shown that oxidatively modiﬁed
proteins are prone to degradation (Powers et al., 2007; Smuder
et al., 2010), which could explain the increased ﬁber atrophy in
hypoxic aged mice. However, we could not detect a signiﬁcant
difference between the levels of skeletal muscle protein
carbonylation in the normoxic mice of the three age groups.
Unexpectedly though, the young mice showed a decreased
level of protein carbonylation in the EDL muscle with pair-
feeding and hypoxia, in contrast to the adult and aged pair-fed
and hypoxic mice in which protein carbonylation was
unchanged. The protein carbonylation in the young mice
correlated with COX activity, which was increased in the
4-week-old mice after hypoxia exposure. Fukuda et al. (2007)
have reported that hypoxia stimulates the HIF-dependent
replacement of COX IV isoform 1 (COX IV-1) with COX IV
isoform 2 (COX IV-2) to optimize efﬁciency of respiration at
lower oxygen concentrations. COX containing the COX IV-2
isoform has been shown to be more active under hypoxic
conditions than COX with the COX IV-1 isoform, but also to
produce less H2O2 in hypoxia (Fukuda et al., 2007). A change in
the composition of the COX protein complex could thus
explain both increased COX activity and lower protein
carbonylation. Future research will have to prove whether the
replacement of COX IV-1 with COX IV-2 occurs in mouse
muscle in vivo and can account for the decrease in protein
carbonylation as observed in this study. However, in mouse
sternohyoid muscle (Lewis et al., 2015) and heart (Ashmore
et al., 2014), 2–3 weeks of hypoxia has previously been shown
to increase protein carbonylation. It is unclear whether our
results diverge from the literature due to a difference in muscle
type (skeletal muscle vs. respiratory muscle and heart), as
reports on protein carbonylation in skeletal muscle after
chronic hypoxia are missing. Alternatively, increased hypoxia-
associated oxidative stress is resolved during the 3 weeks of
exposure. Previous work from our group showed that muscle
atrophy already is ongoing at 4 days into the experiment (de
Theije et al., 2015). Therefore, we are unable to disprove that a
transient increase of carbonylated protein underlies muscle
atrophy in our model (Lewis et al., 2015).
The differential response of the muscle of young, adult, and
aged mice to hypoxia suggests that age does matter and that
the aged mouse is indeed a better model for translation of
ﬁndings to elderly patients with chronic respiratory disease.
In addition to the role of hypoxia in the cachectic processes
of muscle and fat weight loss, we now also show that hypoxia
can reduce expression of markers of mitochondrial
metabolism and shift oxidative ﬁber types to less oxidative
types. Hypoxia-associated effects on Oxphen are subtle, but
compared to the clinical situation of patients with COPD,
loss of Oxphen in this model occurred in a relatively short
time period.
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